IRIS PubliCatt

Rossi, Elena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.189
EU - Europa 1.924
AS - Asia 403
AF - Africa 22
SA - Sud America 15
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.566
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.177
DE - Germania 558
SE - Svezia 410
IT - Italia 321
CN - Cina 240
UA - Ucraina 133
IE - Irlanda 117
FR - Francia 98
PL - Polonia 89
SG - Singapore 86
GB - Regno Unito 57
RU - Federazione Russa 53
FI - Finlandia 34
IN - India 29
CI - Costa d'Avorio 15
AT - Austria 12
BE - Belgio 11
AU - Australia 9
CA - Canada 9
TR - Turchia 9
IR - Iran 8
BR - Brasile 6
CH - Svizzera 5
ES - Italia 5
JP - Giappone 5
KR - Corea 5
RO - Romania 4
ZA - Sudafrica 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
DZ - Algeria 3
HK - Hong Kong 3
IQ - Iraq 3
MY - Malesia 3
VN - Vietnam 3
CL - Cile 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
MX - Messico 2
NL - Olanda 2
NO - Norvegia 2
PE - Perù 2
PT - Portogallo 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
KH - Cambogia 1
LI - Liechtenstein 1
LT - Lituania 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 4.566
Salva come PNG Salva come JPEG
Città #
Chandler 474
Ashburn 209
Dublin 114
Wilmington 91
San Mateo 85
Jacksonville 81
Fairfield 79
Warsaw 74
Ann Arbor 65
Milan 60
Nanjing 60
Dearborn 59
Cattolica 58
Woodbridge 56
Houston 53
New York 53
Rome 52
Boston 49
Singapore 49
Seattle 39
Princeton 38
Marseille 37
Moscow 37
Redwood City 32
Lawrence 25
Nürnberg 25
Beijing 24
Los Angeles 24
Detroit 23
Redmond 23
Nanchang 22
Chicago 21
Cambridge 19
Hangzhou 18
Hebei 17
Bologna 16
Abidjan 15
Kraków 15
Boardman 14
Norwalk 14
Leawood 13
Washington 13
Brussels 11
Munich 10
Bremen 9
Changsha 9
Florence 9
Mountain View 9
San Diego 9
Tianjin 9
Toronto 8
Kunming 7
Pune 7
Busto Arsizio 6
London 6
University Park 6
Vienna 6
Helsinki 5
Izmir 5
Jiaxing 5
Lancaster 5
Perugia 5
Reston 5
Shenyang 5
Simi Valley 5
Andover 4
Clearwater 4
Fremont 4
Glendale 4
Guangzhou 4
Hefei 4
Hounslow 4
Peterborough 4
São Paulo 4
Vladivostok 4
Zhengzhou 4
Baotou 3
Bolzano 3
Busan 3
Cape Town 3
Changchun 3
Dong Ket 3
Hong Kong 3
Jinan 3
Paris 3
Sacramento 3
San Francisco 3
Southend 3
Algiers 2
Amsterdam 2
Bagnacavallo 2
Bagnoli Irpino 2
Bern 2
Budapest 2
Buenos Aires 2
Canberra 2
Chester Springs 2
Essen 2
Falkenstein 2
Ferrara 2
Totale 2.610
Salva come PNG Salva come JPEG
Nome #
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 260
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. 254
Haemostatic alterations induced by treatment with asparaginases and clinical consequences 186
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 163
Risk factor and etiology analysis of ischemic stroke in young adult patients 139
Impact of Radiotherapy on Pain Relief and Recalcification in Plasma Cell Neoplasms : Long-Term Experience. 109
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 109
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 105
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms 102
Fondaparinux in pregnancy: Could it be a safe option? A review of the literature. 102
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 102
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 99
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 98
Bone marrow megakaryocytic activation predicts fibrotic evolution of Philadelphia-negative myeloproliferative neoplasms 97
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms 92
Venous thromboembolism in multiple myeloma 91
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation 89
JAK2 V617F mutational frequency in essential thrombocythemia associated with splanchnic or cerebral vein thrombosis 87
The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia 87
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 80
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 77
Inherited thrombophilia: treatment during pregnancy. 74
Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment 74
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with Vitamin K antagonists 71
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia 70
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 68
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 66
Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives. A review of the Guidelines from Scientific Societies and Working Groups 65
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 65
In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband 63
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 63
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 61
Obstetric complications and pregnancy-related venous thromboembolism: The effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation 60
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 60
Isolated light chain deposition disease neuropathy in a patient with multiple myeloma 60
Assessment of congenital neutropenia in children: common clinical sceneries and clues for management 60
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years 53
Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers 53
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 53
Structural analysis of protein Z gene variants in patients with foetal losses 52
Venous thromboembolism in patients with liver diseases 48
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: A case-control study 47
Splanchnic vein thrombosis in myeloproliferative neoplasms: Risk factors for recurrences in a cohort of 181 patients 46
Cerebral sinus-venous thrombosis 44
G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome 43
Real-world use of thrombopoietin receptor agonists in elderly patients with primary immune thrombocytopenia 43
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population 42
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases 40
Venous thromboembolism in patients with liver diseases 39
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis 39
Second cancers in MPN: Survival analysis from an international study 39
full donor chimerism after allogenic hematopoietic stem cells transplant for myelofibrosis the role of the conditioning regiment 39
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls 38
Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis? 38
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms 36
Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: An expert consensus 34
Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms 33
Contractile reserve of dysfunctional myocardium after revascularization: A dobutamine stress echocardiography study 32
Increased prevalence of the G20210A prothrombin gene variant in acute coronary syndromes without metabolic or acquired risk factors or with limited extent of disease 32
Reassessment of contractile reserve after revascularization of akinetic myocardium 32
Glycoprotein la C807T qene polymorphism and increased risk of recurrent acute coronary syndromes: A five year follow up 27
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 26
Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases 25
Predicting Factors for Seizures after Cerebral Venous Thrombosis: A Retrospective Single Center Cohort Study 23
Predicting Factors for Seizures after Cerebral Venous Thrombosis: A Retrospective Single Center Cohort Study 23
Left atrial myxoma supplied from the right coronary artery 16
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis 10
Risk factor and etiology analysis of ischemic stroke in young adult patients 8
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 8
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 5
G20210A protrombin gene variant and clinical outcome in patients with a first acute coronary syndrome 4
Glycoprotein IA C807T gene polymorphism and increased risk of recurrent acute coronary syndromes: a five year follow up. 4
Totale 4.682
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.799
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.799
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020459 0 28 32 48 44 74 41 15 39 32 63 43
2020/2021467 26 42 20 55 48 37 50 22 54 25 75 13
2021/2022659 46 34 16 39 31 12 20 80 45 45 118 173
2022/20231.331 198 194 114 197 74 155 79 82 151 25 33 29
2023/2024719 28 170 30 51 33 120 36 39 14 31 77 90
2024/202560 26 34 0 0 0 0 0 0 0 0 0 0
Totale 4.682